Endoscopic third ventriculostomy (ETV) has not been recognized as a surgical option for hydrocephalus following aneurysmal subarachnoid hemorrhage (SAH), since hydrocephalus following aneurysmal SAH is considered to result from the communicating component. However, obstructions in the ventricular system may exist, so ETV could help resolve the condition. The present study evaluated the efficacy of ETV for hydrocephalus appearing within one month after aneurysmal SAH. This prospective study evaluated a total of 118 patients admitted to our hospital with aneurysmal SAH. Nine of 66 surgically treated patients suffered hydrocephalus within one month after aneurysmal SAH and 8 underwent ETV. Seven of these 8 patients showed no further ventricular enlargement or deterioration in consciousness, and required no external cerebrospinal fluid (CSF) drainage at least temporarily, and could commence early physical rehabilitation. Four patients also experienced cognitive improvements after ETV, but none made a full cognitive recovery. Ventriculoperitoneal (VP) shunt was implanted for one patient who did not respond to ETV, and the necessity of VP shunt was evaluated including the CSF removal test for the other patients, due to residual cognitive impairment even after initiating the rehabilitation. Five of the 8 patients eventually had VP shunts implanted, and 3 patients, including two patients who improved cognitively after ETV, had further cognitive improvements. ETV for hydrocephalus following aneurysmal SAH is likely to help manage intracranial pressure. ETV may improve cognitive impairment in some patients, but whether the maximum resolution is obtained only with ETV remains uncertain. VP shunt implantation should be the main treatment for hydrocephalus after aneurysmal SAH, but ETV can be employed as a temporary intervention in certain conditions, such as during the waiting period for the clearance of aneurysmal SAH.
Introduction
Hydrocephalus is a complication of aneurysmal subarachnoid hemorrhage (SAH) in 10-30% 6) or 6-67% 4) of patients, and approximately 20% of all such patients ultimately develop shunt-dependent hydrocephalus. 16) Treatment generally depends on implantation of a ventriculoperitoneal (VP) shunt, but opening of the lamina terminalis has been used successfully in combination with aneurysm clipping to prevent the development of hydrocephalus following aneurysmal SAH. 8, 15) Impaired cerebrospinal fluid (CSF) absorption at the arachnoid granules due to fibrosis is generally accepted as a mechanism of hydrocephalus following aneurysmal SAH, 16) but obstruction of the CSF circulation within the ventricular system is also important, 4) since intraventricular hemorrhage (IVH) at initial computed tomography (CT) is a significant predictor of hydrocephalus following aneurysmal SAH. 4, 12, 16) The preventive effect of lamina terminalis fenestration at clipping surgery 8, 15) also indicates that CSF flow obstruction within the ventricular system must be a significant factor. In some cases, the obstructed portion of CSF flow after aneurysmal SAH may be located in the ventricular system, and opening the lamina terminalis can decrease the rate of hydrocephalus occurrence. Therefore, endoscopic third ventriculostomy (ETV) may be an effective treatment of T. Fukuhara et al.
hydrocephalus following aneurysmal SAH.
The present study summarizes our experience with ETV for the treatment of hydrocephalus appearing within one month after aneurysmal SAH, and evaluates the effectiveness and limitations.
Clinical Materials and Methods
The treatment protocol for aneurysmal SAH in our institute requires that patients with incidental nontraumatic SAH are scheduled for emergent conventional angiography within 6 hours of admission, except for patients in Hunt and Kosnik grade V or patients older than 80 years old, who are treated conservatively. If angiography confirms the presence of a ruptured aneurysm, surgery is performed within 24 hours, after excluding any cardiac problems affecting the induction of general anesthesia. If no origin for the SAH is identified, threedimensional CT angiography is performed the next day, and angiography is repeated at least twice. If a ruptured aneurysm is detected, surgery is scheduled within 72 hours of admission if possible or delayed until 2 weeks after admission. We generally use endovascular intervention for posterior circulation aneurysms, and even for some anterior circulation aneurysms, depending on the general condition such as the use of anticoagulant agents. External cisternal and/or external ventricular drainage (EVD) is placed in all open craniotomies, and promptly after the endovascular coiling procedure. No drainage is placed in patients with minimal SAH or undergoing delayed surgery due to initially unknown origin or cardiac problems on admission. After surgery, continuous administration of intravenous diltiazem hydrochloride and ozagrel sodium, and three times daily injection of fasudil hydrochloride are given for 2 weeks to prevent vasospasm. The EVD is removed after confirming the correct functioning of the cisternal drainage, but the EVD is retained if functioning of the cisternal drainage is inadequate.
Our treatment protocol for hydrocephalus following SAH consists of continuous CSF drainage for 3 days, then gradual increase of the height of the chamber, and attempted removal of drainage within 7 days. However, if ventricular enlargement or deterioration of consciousness occurs while clamping the drainage, the drainage will be kept in place for another week at the height of 20 cmH 2 O from the external auditory meatus. In our institute, VP shunt implantation is postponed for at least one month after aneurysm rupture to achieve better shunt patency. If external CSF drainage is still necessary within a month of an aneurysmal SAH event, then reinstallation of the EVD will be considered. This study regards this condition as hydrocephalus occurring within one month after aneurysmal SAH, and recognizes two modes: Enlarged ventricles occurring within one month after drain removal with consciousness disturbance; and continued flow of more than 200 ml/day of CSF at 2 weeks after aneurysm rupture preventing drain removal. Both conditions are considered to be high risk without external CSF drainage, and thus indicate prompt reinstallation of the EVD.
In the explanation of treatment to the patient's family, the option of ETV is discussed. The advantage is possible resolution of hydrocephalus without the need for external drainage of CSF, although the success rate is unknown. However, ETV carries the surgical risk of third ventriculostomy but risks related to general anesthesia, since EVD can be placed under local anesthesia. We emphasize that VP shunt implantation will probably be necessary if hydrocephalus persists even after ETV. If the patient's family wishes to proceed, ETV is performed at the reinstallation of EVD. An intracranial pressure (ICP) monitoring system is also placed if available, and involves preoperative implantation of the ICP sensor at the bedside for measuring ICP overnight, and continuous monitoring for 3 days postoperatively. The EVD will not be opened unless clinical signs indicate increased ICP. This clinical study was approved as institutionally funded research in April 2002.
A total of 118 patients with nontraumatic incidental SAH were admitted to our institute between April 2002 and March 2006. No surgical treatment was recommended for 46 patients because of grade V on admission (23 patients), older than 80 years (14 patients), or unknown origin even after repeated cerebral angiography (9 patients). Clipping surgery could not be completed due to cardiac problems in 6 patients (4 acute myocardial infarction and 2 ampulla cardiomyopathy), which lead to their deaths. Sixty-six patients were treated surgically (59 clipping and 7 coiling), but no CSF drainage was placed in 7 patients because of minimal aneurysmal SAH or aneurysmal SAH already washed out due to the delayed intervention. Four of the 59 patients who had CSF drainage at the time of aneurysm surgery died within 2 weeks of the surgery due to uncontrollable increases in ICP. Nine patients developed hydrocephalus within one month after aneurysmal SAH to the extent that replacement of the EVD seemed necessary. Hydrocephalus was due to enlarged ventricles in 5 patients, and drain removal failure in 4. The option of ETV at EVD replacement was explained to the families of these 9 patients. The family of a patient with unruptured basilar artery aneurysm refused this option due to the considerably higher risk of ETV. The remaining 8 patients received ETV at replacement of the EVD. Figure 1 shows the flow chart detailing how the study population was selected. Clinical features and outcomes, including the effect of ETV and successive VP shunt implantation, if performed, were evaluated.
Results
The rate of hydrocephalus occurring within a month was calculated as 14.5%, based on 9 of 62 surgically treated patients surviving at one month after aneurysmal SAH. However, the total incidence of hydrocephalus was 34.4% in patients treated with VP shunt implantation and/or ETV within 6 months, based on 21 of 61 surgically treated patients surviving at 6 months after aneurysmal SAH. The clinical features of the 8 patients who underwent ETV for hydrocephalus following aneurysmal SAH are described in Table 1 . Patients were older at 51-79 years old, and the grade at presentation tended to be high, with 5 patients in grade IV. CT revealed thick clots in all patients except one (Case 2), who had a diffuse thin clot but also IVH in the fourth ventricle. Therefore, all patients had aneurysmal SAH corresponding to Fisher grade 3 or 4. One patient with an aneurysm localized on the posterior circulation (Case 1) underwent intravascular embolization, and another patient with a left posterior communicating artery aneurysm (Case 8) also underwent embolization, since she had been receiving oral warfarin for prior venous thrombosis. Symptomatic spasms occurred after surgery in 3 patients. Table 2 summarizes the results of ETV and patient outcomes. The external CSF drainage could be removed in 5 patients, but progressive enlargement of the ventricles was observed together with consciousness disturbance, so the EVD was replaced. The CSF drainage could not be removed 2 weeks after aneurysm rupture in the other 3 patients, so replace- (Fig. 2) . Improvement in consciousness (e.g., eye opening or motor reactions to verbal stimulation) was seen in 5 patients, and cognitive recovery (e.g., appropriate reactions to verbal commands) in 4 patients. Ventricular enlargement continued in Case 8 even after ETV, so continuous CSF drainage was necessary. Case 8 was the only patient who was unresponsive to ETV. VP shunt implantation was postponed, due to a prolonged serious skin rash caused by allergic reactions to antibiotics, so lumbar drainage was placed for 2 months. The patient's consciousness improved immediately after the VP shunt was implanted. However, her cognition was seriously impaired, so she was dependent in all her daily activities (severe disability on Glasgow Outcome Scale) despite intense rehabilitation. Case 6 responded to ETV quite well, so rehabilitation was initiated within a week, but she suffered lung embolization at the very beginning of standing rehabilitation, and eventually died.
VP shunt implantation was considered in the other 6 patients, since all had some level of cognitive impairment and enlarged ventricles even after ETV. Cases 5 and 7 with large intraparenchymal hemorrhages (IPHs) on admission did not exhibit improved consciousness, although no further ventricular enlargement occurred after ETV. Significant recovery after VP shunt implantation was quite unlikely with such large IPHs, so CSF removal tests were performed to assess the prognosis for VP shunt implan- 
Discussion
In our institute, VP shunt implantation is generally postponed until at least one month has passed to improve VP shunt patency. Prior to this study, we usually only replaced the EVD if hydrocephalus appeared within a month after aneurysmal SAH. The present clinical study compared the advantages of ETV against the added risk of the ETV procedure. We found no operative complications with ETV, so we believe the benefits outweigh the possible harm. This study only examined hydrocephalus appearing within a month after aneurysmal SAH, so we cannot speculate on any other types. In addition, the patient was treated conservatively even with hydrocephalus occurring within a month, if the symptoms were not emergent. Therefore, all cases of hydrocephalus in this study were associated with emergent conditions. The number of cases is still not enough to draw conclusions about the efficacy of ETV on this type of hydrocephalus. However, some characteristics of ETV were revealed.
Seven of the 8 patients could be released from external CSF drainage after ETV with stable ventricular size and no further consciousness deterioration, but two patients with IPH did not show improved consciousness. Therefore, ETV performed for hydrocephalus following aneurysmal SAH may achieve control of increased ICP. Physical rehabilitation was initiated within a week after ETV in these 7 patients. Since early rehabilitation is critical for the recovery of elderly patients with consciousness disturbance, 11) this is a significant advantage of ETV. Increased ICP due to hydrocephalus following aneurysmal SAH during this period is probably the result of an obstructive mechanism in the ventricular system, and this condition can be resolved with ETV. However, we should note that ICP was monitored in only 3 patients, and whether the reduction of ICP observed after ETV is adequate for full recovery remains unclear.
Hydrocephalus after aneurysmal SAH can be classified into 3 stages, 16) with hydrocephalus occurring more than 2 weeks after aneurysmal SAH classified as chronic hydrocephalus. Since external CSF drainage is usually maintained in place for more than a week, acute (0-3 days) and subacute (4-13 days) hydrocephalus cannot be distinguished. We divided the mode of hydrocephalus into``enlarged ventricles'' and``drain removal failure,'' since we speculate that the mode of hydrocephalus may affect the result.``Drain removal failure'' can be regarded as hydrocephalus with more acute onset and is more likely to involve the obstructive component, compared with``enlarged ventricles'' hydrocephalus, which can be classified as``chronic hydrocephalus.'' 16) However, our findings do not give any insights. More studies are necessary to understand this point.
Four patients showed some cognitive improvement after ETV. This is also an attractive advantage of ETV, but we should be aware that no patient achieved full cognitive recovery after only ETV. Aneurysmal SAH can also cause impaired cognition or other neurological deficits, so whether VP shunt implantation will resolve residual neurological deficits in patients with enlarged ventricles compared to admission is quite difficult to determine. Two patients recovered completely after VP shunt implantation, suggesting only ETV was not sufficient. However, for the two patients who did not improve after VP shunt implantation, ETV seemed to be the essential treatment. Only ETV may alleviate all symptoms in some patients, but they are difficult to identify. How to estimate the effect of VP shunt implantation for ventriculomegaly after aneurysmal SAH has been long discussed, but still no reliable methods have been established. 3, 10) There-
fore, we still recommend VP shunting for this type of hydrocephalus when appropriate.
Three of the 8 patients definitely required VP shunt implantation, one for no response to ETV and two for incomplete cognitive impairment, which completely resolved after shunting. The limited number of patients makes common tendencies difficult to determine, but both patients who were treated with endovascular coiling procedures were included in these 3 patients. Hydrocephalus following aneurysmal SAH is essentially communicating, and washing out SAH during clipping surgery and cisternal drainage placement may reduce the risk of communicating hydrocephalus. Since neither washing out SAH following craniotomy nor cisternal drainage placement can be performed after the coiling procedure, hydrocephalus in such patients may be difficult to resolve only with ETV.
The timing of VP shunting after aneurysmal SAH has not been established, 1) and we are not sure whether one month is adequate for delaying VP shunt implantation. Indeed, delay of VP shunt implantation after aneurysmal SAH is not mandatory, and VP shunting has been performed even within days of aneurysmal SAH. 14) An observation period of at least 2 weeks has been recommended, considering the time required to develop fibrosis of the meninges as a consequence of aneurysmal SAH. 16) We also believe that a washout period of red blood cells in CSF, which can cause shunt failure, is also desirable. 1, 2) External drainage placement after aneurysmal surgery is often prolonged in our institute, which may induce bacterial colonization, 9) although we did not confirm any cases of meningitis in our study. It is advantageous to wait as long as possible for bacterial elimination before VP shunt implantation. 7) Although a VP shunt implanted within one month may have a higher rate of failure, the fenestration made by ETV after aneurysmal SAH also carries a risk of obstruction. 13) Therefore, careful observation to detect hydrocephalus recurrence is necessary even after effective ETV, since we found that reclosure of the fenestration can occur within 15 days after ETV. 5) ETV offers an effective option for controlling increased ICP associated with hydrocephalus after aneurysmal SAH, and will also help to improve cognitive function, but this effect is limited. Since whether the maximum resolution is obtained with ETV is hard to confirm, VP shunt implantation should be the main treatment for hydrocephalus with impaired cognitive function. ETV is a temporary intervention in limited conditions, such as during the waiting period for the clearance of aneurysmal SAH.
